<p>Distribution of explanatory variables between patients receiving cetuximab and those not receiving cetuximab for propensity score quintiles ranging from 1 (least likely to receive cetuximab) to 5 (most likely to receive cetxuimab).</p
Distribution of mild, moderate, and severe patients, based on the five approaches used in the study....
<p>Percent of patients having between 0 and 8 detected medications in the Residuals vs. Reconciled c...
<p>Distribution of predicted probabilities for antimicrobial (a) and non-antimicrobial (b) samples.<...
<p>Distribution of explanatory variables between patients receiving influenza vaccine and those not ...
<p>Distribution of explanatory variables between patients in high-use and low-use TKA hospitals.</p
<p>Distribution of explanatory variables between patients in high-use and low-use TKA hospitals and ...
<p>Distribution of Variables in Patients with (EPC+) and Without (EPC-) Circulating EPC.</p
<p>Distribution of coinfected and non-coinfected patients according to demographical and clinical va...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
Distribution of tumor grading and adjuvant chemotherapy regimens is shown for the patient cohorts wi...
<p>Distribution of coinfected and non-coinfected patients according the mean of NFI at all the momen...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of clinical variables across the different subgroups according to the combined Synta...
Distribution of the patients according to present treatment-related factors (n = 259).</p
Distribution of mild, moderate, and severe patients, based on the five approaches used in the study....
<p>Percent of patients having between 0 and 8 detected medications in the Residuals vs. Reconciled c...
<p>Distribution of predicted probabilities for antimicrobial (a) and non-antimicrobial (b) samples.<...
<p>Distribution of explanatory variables between patients receiving influenza vaccine and those not ...
<p>Distribution of explanatory variables between patients in high-use and low-use TKA hospitals.</p
<p>Distribution of explanatory variables between patients in high-use and low-use TKA hospitals and ...
<p>Distribution of Variables in Patients with (EPC+) and Without (EPC-) Circulating EPC.</p
<p>Distribution of coinfected and non-coinfected patients according to demographical and clinical va...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
Distribution of tumor grading and adjuvant chemotherapy regimens is shown for the patient cohorts wi...
<p>Distribution of coinfected and non-coinfected patients according the mean of NFI at all the momen...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of delays since onset of symptoms to start of treatment for patients that do not dro...
<p>Distribution of clinical variables across the different subgroups according to the combined Synta...
Distribution of the patients according to present treatment-related factors (n = 259).</p
Distribution of mild, moderate, and severe patients, based on the five approaches used in the study....
<p>Percent of patients having between 0 and 8 detected medications in the Residuals vs. Reconciled c...
<p>Distribution of predicted probabilities for antimicrobial (a) and non-antimicrobial (b) samples.<...